Cargando…

Is Clozapine-induced Weight Gain Dose-dependent? Results From a Prospective Cohort Study

BACKGROUND: Antipsychotic-induced metabolic adverse effects are risk factors for cardiometabolic comorbidities. Whether dose lowering could mitigate such effects remains unclear. The present study aims to investigate the associations between clozapine doses and modifications of weight, blood pressur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piras, Marianna, Chahma, Jihane, Ranjbar, Setareh, Laaboub, Nermine, Grosu, Claire, Plessen, Kerstin Jessica, von Gunten, Armin, Conus, Philippe, Eap, Chin Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Regular Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318871/ https://www.ncbi.nlm.nih.gov/pubmed/36841954 http://dx.doi.org/10.1093/schbul/sbad009

Ejemplares similares

Olanzapine‐associated dose‐dependent alterations for weight and metabolic parameters in a prospective cohort
por: Schoretsanitis, Georgios, et al.
Publicado: (2022)

Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysis
por: Sjaarda, Jennifer, et al.
Publicado: (2023)

Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort
por: Laaboub, Nermine, et al.
Publicado: (2022)

Publisher Correction: Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort
por: Laaboub, Nermine, et al.
Publicado: (2022)

Effects of psychotropic switches on weight change: a prospective cohort study
por: Piras, M., et al.
Publicado: (2022)

Associations Between High Plasma Methylxanthine Levels, Sleep Disorders and Polygenic Risk Scores of Caffeine Consumption or Sleep Duration in a Swiss Psychiatric Cohort
por: Laaboub, Nermine, et al.
Publicado: (2021)

Metabolic disturbances are associated with psychiatric readmission: results from a Swiss psychiatric cohort
por: Laaboub, N., et al.
Publicado: (2022)

DNA methylation may mediate psychotropic drug-induced metabolic side effects: results from a 1-month observational study
por: Dubath, C., et al.
Publicado: (2022)

Metabolomic alteration induced by psychotropic drugs: Short‐term metabolite profile as a predictor of weight gain evolution
por: Lenski, Marie, et al.
Publicado: (2021)

Psychotropic drug-induced genetic-epigenetic modulation of CRTC1 gene is associated with early weight gain in a prospective study of psychiatric patients
por: Delacrétaz, Aurélie, et al.
Publicado: (2019)

Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort
por: Dubath, Céline, et al.
Publicado: (2021)

Correction: Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort
por: Dubath, Céline, et al.
Publicado: (2021)

Addition of Aripiprazole to the Clozapine May Be Useful in Reducing Anxiety in Treatment-Resistant Schizophrenia
por: Chanachev, Aleksandar, et al.
Publicado: (2011)

The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samples
por: Perry, Benjamin I., et al.
Publicado: (2022)

Weight gain and metabolic disorders induced by psychotropic drugs: an appraisal of risk factors
por: Eap, C. B.
Publicado: (2023)

Clinical, genetic and environmental influences on weight gain and metabolic disorders induced by psychotropic drugs
por: Eap, C.
Publicado: (2022)

Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis
por: Kuzo, Nazar, et al.
Publicado: (2022)

Association Between Plasma Caffeine and Other Methylxanthines and Metabolic Parameters in a Psychiatric Population Treated With Psychotropic Drugs Inducing Metabolic Disturbances
por: Delacrétaz, Aurélie, et al.
Publicado: (2018)

Weight gain in childhood and blood lipids in adolescence
por: Horta, Bernardo L, et al.
Publicado: (2009)

The Effect of Clozapine on Premature Mortality: An Assessment of Clinical Monitoring and Other Potential Confounders
por: Hayes, Richard D., et al.
Publicado: (2015)

Weight gain in freshman college students and perceived health
por: de Vos, Paul, et al.
Publicado: (2015)

Metformin for treatment of clozapine-induced weight gain in adult patients with schizophrenia: a meta-analysis
por: LIU, Zhengrong, et al.
Publicado: (2015)

Opposing effects of clozapine and brexpiprazole on β-aminoisobutyric acid: Pathophysiology of antipsychotics-induced weight gain
por: Fukuyama, Kouji, et al.
Publicado: (2023)

Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant Schizophrenia
por: McQueen, Grant, et al.
Publicado: (2021)

Association of weight gain and metabolic syndrome in patient taking Clozapine: a 8-year cohort study
por: Bai, Ya Mei, et al.
Publicado: (2010)

The role of self-regulatory control processes in understanding aggressive ideations and behaviors: An experience sampling method study
por: Plessen, Kerstin Jessica, et al.
Publicado: (2023)

Weight gain in childhood and body composition at 18 years of age in Brazilian males
por: Victora, Cesar G, et al.
Publicado: (2007)

Cluster Analysis of Clozapine Consumer Perspectives and Comparison to Consumers on Other Antipsychotics
por: Sharma, Sumeet, et al.
Publicado: (2021)

Excess pregnancy weight gain in latinas: Impact on infant’s adiposity and growth hormones at birth
por: Elwan, Deena, et al.
Publicado: (2021)

Do Adult Attachment Style or Personality Mediate the Relationship Between Childhood Maltreatment and Late-Life Depression in Poor Communities?
por: Gomes Jardim, Gabriel Behr, et al.
Publicado: (2022)

Influence of MCHR2 and MCHR2-AS1 Genetic Polymorphisms on Body Mass Index in Psychiatric Patients and In Population-Based Subjects with Present or Past Atypical Depression
por: Delacrétaz, Aurélie, et al.
Publicado: (2015)

Weighted Genetic Risk Scores and Prediction of Weight Gain in Solid Organ Transplant Populations
por: Saigi-Morgui, Núria, et al.
Publicado: (2016)

The Effect of Ranitidine on Olanzapine-Induced Weight Gain
por: Ranjbar, Fatemeh, et al.
Publicado: (2013)

Risk of breast cancer in young women in relation to body size and weight gain in adolescence and early adulthood
por: Coates, R J, et al.
Publicado: (1999)

Gardening and age-related weight gain: Results from a cross-sectional survey of Denver residents
por: Litt, Jill S., et al.
Publicado: (2017)

N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis
por: Conus, Philippe, et al.
Publicado: (2018)

Potential Role of Patients’ CYP3A-Status in Clozapine Pharmacokinetics
por: Tóth, Katalin, et al.
Publicado: (2017)

Implementing higher oxygen saturation targets reduced the impact of poor weight gain as a predictor for retinopathy of prematurity
por: Lundgren, Pia, et al.
Publicado: (2017)

Examining the role of pre‐pregnancy weight and gestational weight gain in allergic disease development among offspring: A population‐based cohort study in Ontario, Canada
por: Srugo, Sebastian A., et al.
Publicado: (2021)

Reducing the Risk of Withdrawal Symptoms and Relapse Following Clozapine Discontinuation—Is It Feasible to Develop Evidence-Based Guidelines?
por: Blackman, Graham, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f55hg4qf3064h03blca4ded6td